Kilroy Conor
See Remarks
Kilroy Conor has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.
On the most recent filing, Kilroy Conor is listed as See Remarks at Aura Biosciences, Inc. Inside the rolling window, Kilroy Conor reported no open-market purchases and 2 open-market sales totaling $143K in AURA. The largest disclosed transaction in the window is a sale of 11,738 AURA shares on Apr 16, 2026, worth $82K.
Companies traded
Other insiders at AURA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$143K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kilroy Conor made?
Kilroy Conor has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Kilroy Conor trade?
Kilroy Conor has filed SEC Form 4 disclosures for 1 company, including AURA.
When was Kilroy Conor's most recent SEC Form 4 filing?
Kilroy Conor's most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.
What is Kilroy Conor's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kilroy Conor is listed as See Remarks.
What is Kilroy Conor's total buy and sell value in the current window?
Inside the rolling retention window, Kilroy Conor bought $0 and sold $143K based on SEC Form 4 filings.
What was Kilroy Conor's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,738 AURA shares on 2026-04-16, worth $82K, per SEC Form 4 filings.